Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

BACKGROUND: The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel(®) was assessed in malaria–experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium falciparum FVO clone adsorbed to Alhydrogel(®), the...

Descripción completa

Detalles Bibliográficos
Autores principales: Thera, Mahamadou A., Coulibaly, Drissa, Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Sall, Abdourhamane H., Diarra, Issa, Daou, Modibo, Traore, Idrissa M., Tolo, Youssouf, Sissoko, Mady, Niangaly, Amadou, Arama, Charles, Baby, Mounirou, Kouriba, Bourema, Sissoko, Mahamadou S., Sagara, Issaka, Toure, Ousmane B., Dolo, Amagana, Diallo, Dapa A., Remarque, Edmond, Chilengi, Roma, Noor, Ramadhani, Sesay, Sanie, Thomas, Alan, Kocken, Clemens H., Faber, Bart W., Imoukhuede, Egeruan Babatunde, Leroy, Odile, Doumbo, Ogobara K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006270/
https://www.ncbi.nlm.nih.gov/pubmed/27577237
http://dx.doi.org/10.1186/s12936-016-1466-4

Ejemplares similares

Ejemplares similares